Replication factor C3 is a CREB target gene that regulates cell cycle progression through the modulation of chromatin loading of PCNA

被引:37
作者
Chae, H-D [1 ]
Mitton, B. [1 ]
Lacayo, N. J. [1 ]
Sakamoto, K. M. [1 ]
机构
[1] Stanford Univ, Dept Pediat, Div Hematol Oncol, Sch Med, Stanford, CA 94305 USA
关键词
ELEMENT-BINDING-PROTEIN; ACUTE MYELOID-LEUKEMIA; DEPENDENT KINASES; EXPRESSION; CANCER; TRANSFORMATION; PROLIFERATION; HEMATOPOIESIS; TRANSCRIPTOME; STABILITY;
D O I
10.1038/leu.2014.350
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
CREB (cyclic AMP response element-binding protein) is a transcription factor overexpressed in normal and neoplastic myelopoiesis and regulates cell cycle progression, although its oncogenic mechanism has not been well characterized. Replication factor C3 (RFC3) is required for chromatin loading of proliferating cell nuclear antigen (PCNA) which is a sliding clamp platform for recruiting numerous proteins in the DNA metabolism. CREB1 expression, which was activated by E2F, was coupled with RFC3 expression during the G1/S progression in the KG-1 acute myeloid leukemia (AML) cell line. There was also a direct correlation between the expression of RFC3 and CREB1 in human AML cell lines as well as in the AML cells from the patients. CREB interacted directly with the CRE site in RFC3 promoter region. CREB-knockdown inhibited primarily G1/S cell cycle transition by decreasing the expression of RFC3 as well as PCNA loading onto the chromatin. Exogenous expression of RFC3 was sufficient to rescue the impaired G1/S progression and PCNA chromatin loading caused by CREB knockdown. These studies suggest that RFC3 may have a role in neoplastic myelopoiesis by promoting the G1/S progression and its expression is regulated by CREB.
引用
收藏
页码:1379 / 1389
页数:11
相关论文
共 40 条
[1]
Human single-stranded DNA binding proteins are essential for maintaining genomic stability [J].
Ashton, Nicholas W. ;
Bolderson, Emma ;
Cubeddu, Liza ;
O'Byrne, Kenneth J. ;
Richard, Derek J. .
BMC MOLECULAR BIOLOGY, 2013, 14
[2]
Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: Oncogenic and immunomodulations involving the action of tumor necrosis factor [J].
Bakshi, Shlomo ;
Zhang, Xiang ;
Godoy-Tundidor, Sonia ;
Cheng, Robert Yuk Sing ;
Sartor, Maureen A. ;
Medvedovic, Mario ;
Ho, Shuk-Mei .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2008, 116 (06) :769-776
[3]
EpCAM regulates cell cycle progression via control of cyclin D1 expression [J].
Chaves-Perez, A. ;
Mack, B. ;
Maetzel, D. ;
Kremling, H. ;
Eggert, C. ;
Harreus, U. ;
Gires, O. .
ONCOGENE, 2013, 32 (05) :641-650
[4]
Emerging roles of E2Fs in cancer: an exit from cell cycle control [J].
Chen, Hui-Zi ;
Tsai, Shih-Yin ;
Leone, Gustavo .
NATURE REVIEWS CANCER, 2009, 9 (11) :785-797
[5]
CREB is a critical regulator of normal hematopoiesis and leukemogenesis [J].
Cheng, Jerry C. ;
Kinjo, Kentaro ;
Judelson, Dejah R. ;
Chang, Jenny ;
Wu, Winston S. ;
Schmid, Ingrid ;
Shankar, Deepa B. ;
Kasahara, Noriyuki ;
Stripecke, Renata ;
Bhatia, Ravi ;
Landaw, Elliot M. ;
Sakamoto, Kathleen M. .
BLOOD, 2008, 111 (03) :1182-1192
[6]
Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia [J].
Crans-Vargas, HN ;
Landaw, EM ;
Bhatia, S ;
Sandusky, G ;
Moore, TB ;
Sakamoto, KM .
BLOOD, 2002, 99 (07) :2617-2619
[7]
Evolutionary relationships and structural mechanisms of AAA plus proteins [J].
Erzberger, Jan P. ;
Berger, James M. .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2006, 35 :93-114
[8]
Genetics of myeloid malignancies:: Pathogenetic and clinical implications [J].
Fröhling, S ;
Scholl, C ;
Gilliland, DG ;
Levine, RL .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) :6285-6295
[9]
Application of housekeeping npcRNAs for quantitative expression analysis of human transcriptome by real-time PCR [J].
Galiveti, Chenna R. ;
Rozhdestvensky, Timofey S. ;
Brosius, Juergen ;
Lehrach, Hans ;
Konthur, Zoltan .
RNA, 2010, 16 (02) :450-461
[10]
Multiple roles for kinases in DNA replication [J].
Henneke, G ;
Koundrioukoff, S ;
Hübscher, W .
EMBO REPORTS, 2003, 4 (03) :252-256